K-ras codon 12 mutations of the super-minute dysplasia in Barrett's esophagus by DNA extraction using a microdissection method

Diseases of the Esophagus

Volumn 16, Issue 3, 2003, Pages 214-217

  Wada, Ryo ^a,b   Yamaguchi, T ^c  

^a JUNTENDO UNIVERSITY SHIZUOKA HOSPITAL   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c BioMedical Laboratories Inc   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DNA; PROTEIN P53;

ADENOCARCINOMA; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; BARRETT ESOPHAGUS; CANCER GRADING; CODON; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISSECTION; DNA EXTRACTION; DYSPLASIA; ESOPHAGUS CANCER; ESOPHAGUS MUCOSA; GENE MUTATION; HISTOGENESIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABELING INDEX; MORPHOLOGY; MUTATIONAL ANALYSIS; ONCOGENE K RAS; PRIORITY JOURNAL;

BARRETT ESOPHAGUS; CODON; DNA; DNA MUTATIONAL ANALYSIS; GENES, RAS; HUMANS; MICRODISSECTION; MUTATION;

EID: 0242690391     PISSN: 11208694     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2050.2003.00331.x     Document Type: Article

References (17)

1. Morson B C. Carcinoma arising from areas of intestinal metaplasia in the gastric mucosa. Br J Cancer 1955; 9: 377-85.
2. Wada R, Abe H, Matsukuma S, Kuwabara N, Suda K. Histogenesis of the gastric differentiated adenocarcinoma - Expression of oncogene protein products and mucin histochemistry in minute gastric cancer. Oncol Rep 1996; 3: 901-5.
3. Shamsuddin A K M. Microscopic intraepithelial neoplasia in large bowel mucosa. Human Pathol 1982; 13: 510-12.
4. Wada R, Matsukuma S, Abe H et al. Histopathological studies of superficial-type early colorectal carcinoma. Cancer 1996; 77: 44-50.
5. Barrett N R. Chronic peptic ulcer of the esophagus and oesophagitis. Br J Surg 1950; 38: 175-82.
6. Paull A, Trier J S, Dalton M D, Camp R C, Loeb P, Goyal R K. The histologic spectrum of Barrett's esophagus. N Engl J Med 1976; 295: 476-80.
7. Haggitt R C, Tryzelaar J, Ellis F H, Colcher H. Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus. Am J Clin Pathol 1978; 70: 1-5.
8. Casson A G, Mukhopadlhyay T, Cleary K R, Ro J Y, Levin B, Roth J A. p53 gene mutations in Barrett's epithelium and esophageal cancer. Cancer Res 1991; 51: 4495-9.
9. Hardwick R H, Shepherd N A, Moorghen M, Newcomb P V, Alderson D. Adenocarcinoma arising in Barrett's oesophagus: Evidence for participation of p53 dysfunction in the dysplasia/carcinoma sequence. Gut 1994; 35: 764-8.
10. Schneider P M, Casson A G, Levin B et al. Mutations of p53 in Barrett's esophagus and Barrett's cancer: A prospective study of ninety-eight cases. J Thorac Cardiovasc Surg 1996; 111: 323-33.
11. Trautmann B, Wittekind C, Strobel D et al. K-ras point mutations are rare events in premalignant forms of Barrett's oesophagus. Eur J Gastroenterol Hepatol 1996; 8: 799-804.
12. Ireland A P, Clark G W B, De Meester R. Barrett's esophagus. The significance of p53 in clinical practice. Ann Surg 1997; 225: 17-30.
13. Lord R V, O'Grady R, Sheehan C, Field A F, Ward R L. K-ras codon 12 mutations in Barrett's oesophagus and adenocarcinomas of the oesophagus and oesophagastric junction. J Gastroenterol Hepatol 2000; 15: 730-6.
14. Kimura H, Konishi K, Kaji M, Maeda K, Yabushita K, Miwa A. p53 immunoreactivity in Barrett's metaplasia, dysplasia, and adenocarcinoma - A case report. Hepatogastroenterology 2001; 48: 1662-4.
15. Weston A P, Banerjee S K, Sharma P, Tran T M, Richards R, Cherian R. p53 protein overexpression in low grade dysplasia (LGD) in Barrett's esophagus: Immunohistochemical marker predictive of progression. Am J Gastroenterol 2001; 96: 1321-3.
16. Skinner D B, Walther B C, Little A G. Surgical treatment of Barrett's esophagus. In: Spechler, S J et al., (eds) Barrett's Esophagus, Pathophysiology, Diagnosis, and Management. New York: Elsevier. Sci Publications Co 1985, 211-21.
17. Matsubayashi H, Watanabe H, Yamaguchi T et al. Difference in mucus and K-ras mutation in relation to phenotypes of tumors of the papilla of Vater. Cancer 1999; 86: 596-607.